Home / TMLHE Knockout Cell Lines

TMLHE Knockout Cell Lines

Gene: TMLHE

Official Full Name: trimethyllysine hydroxylase, epsilonprovided by HGNC

Gene Summary: This gene encodes the protein trimethyllysine dioxygenase which is the first enzyme in the carnitine biosynthesis pathway. Carnitine play an essential role in the transport of activated fatty acids across the inner mitochondrial membrane. The encoded protein converts trimethyllysine into hydroxytrimethyllysine. A pseudogene of this gene is found on chromosome X. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO13162 TMLHE Knockout cell line (HeLa) Human TMLHE 1:3~1:6 Negative Online Inquiry
KO13163 TMLHE Knockout cell line (HCT 116) Human TMLHE 1:2~1:4 Negative Online Inquiry
KO13164 TMLHE Knockout cell line (HEK293) Human TMLHE 1:3~1:6 Negative Online Inquiry
KO13165 TMLHE Knockout cell line (A549) Human TMLHE 1:3~1:4 Negative Online Inquiry

Background

TMLHE Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to study the functional implications of the TMLHE gene through targeted gene disruption. TMLHE (trimethyllysine hydroxylase erythropoietic) plays a crucial role in metabolizing trimethyllysine to 3-hydroxy trimethyllysine, an important step in the biosynthesis of carnitine, which is essential for fatty acid metabolism and energy production in cells. These knockout cell lines facilitate the examination of TMLHE's role in cellular metabolism, signaling pathways, and various disease states.

The mechanism of action involves the use of CRISPR-Cas9 technology to create specific deletions in the TMLHE gene, effectively generating a loss-of-function model. This allows researchers to observe phenotypic changes, abnormal metabolic profiles, and potential compensatory mechanisms triggered by the absence of TMLHE expression. The ability to manipulate this gene at a cellular level is indispensable for understanding both normal physiological processes and pathological conditions related to energy metabolism disorders.

In research and clinical applications, TMLHE Gene Knockout Cell Lines serve as an invaluable tool for investigating the biochemical and cellular processes influenced by TMLHE, thus contributing to the discovery of novel therapeutic targets in metabolic diseases. Furthermore, these cell lines are pivotal in drug discovery and the development of gene therapies, where a clear understanding of gene function is critical.

What sets our TMLHE Gene Knockout Cell Lines apart from alternatives is their high specificity and reproducibility, ensuring consistent results across experiments. The characterizations provided with these cell lines, including detailed genotyping and functional validation, equip researchers with confidence when advancing their studies.

For researchers and clinicians, our TMLHE Gene Knockout Cell Lines not only enable cutting-edge investigations into the metabolic functions of TMLHE but also advance understanding of related health issues, potentially leading to improved therapeutic strategies. Our company's commitment to precision in biogenetics and extensive experience in product development ensures that researchers have the reliable resources they need to explore the complexities of gene function in health and disease.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.